A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers

NCT01363999 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: atorvastatin
DRUG: dalcetrapib

Sponsor

Hoffmann-La Roche